Gel-mediated Delivery of AAV1 Vectors Corrects Ventilatory Function in Pompe Mice With Established Disease
Open Access
- 1 March 2010
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy
- Vol. 18 (3), 502-510
- https://doi.org/10.1038/mt.2009.305
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapyProceedings of the National Academy of Sciences, 2009
- Neural deficits contribute to respiratory insufficiency in Pompe diseaseProceedings of the National Academy of Sciences, 2009
- Systemic delivery of AAV8 in utero results in gene expression in diaphragm and limb muscle: treatment implications for muscle disordersGene Therapy, 2009
- Induction of Immune Tolerance to FIX Following Muscular AAV Gene Transfer Is AAV-dose/FIX-level DependentMolecular Therapy, 2009
- Correction of Multiple Striated Muscles in Murine Pompe Disease Through Adeno-associated Virus–mediated Gene TherapyMolecular Therapy, 2008
- Neonatal Intraperitoneal or Intravenous Injections of Recombinant Adeno-Associated Virus Type 8 Transduce Dorsal Root Ganglia and Lower Motor NeuronsHuman Gene Therapy, 2008
- Fatigue: an important feature of late-onset Pompe diseaseZeitschrift für Neurologie, 2007
- Induction of Robust Immune Responses against Human Immunodeficiency Virus Is Supported by the Inherent Tropism of Adeno-Associated Virus Type 5 forDendritic CellsJournal of Virology, 2006
- Unique Biologic Properties of Recombinant AAV1 Transduction in Polarized Human Airway EpitheliaPublished by Elsevier BV ,2006
- α2,3 and α2,6 N-Linked Sialic Acids Facilitate Efficient Binding and Transduction by Adeno-Associated Virus Types 1 and 6Journal of Virology, 2006